Titanium Dioxide Nanoparticles Catalyze Brain Tumor Death
Thursday, September 24, 2009 - 06:28
in Health & Medicine
(PhysOrg.com) -- Scientists from the U.S. Department of Energy`s (DOE) Argonne National Laboratory and the University of Chicago Medical Center`s Brain Tumor Center have developed a way to target brain cancer cells using inorganic titanium dioxide nanoparticles bonded to antibodies. Thousands of people die from malignant brain tumors every year, and the tumors are often resistant to conventional therapies. These composite nanoparticles eventually may provide an alternative form of therapy that targets only cancer cells and does not affect normal living tissue.